Discontinuation report MYCOPHENOLATE MOFETIL FOR INJECTION USP
Report ID | 216963 |
Drug Identification Number | 02479974 |
Brand name | MYCOPHENOLATE MOFETIL FOR INJECTION USP |
Common or Proper name | MYCOPHENOLATE MOFETIL FOR INJECTION USP |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | MYCOPHENOLATE MOFETIL |
Strength(s) | 500MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 4 VIALS |
ATC code | L04AA |
ATC description | IMMUNOSUPPRESSANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2024-02-01 |
Actual discontinuation date | 2024-06-30 |
Remaining supply date | 2024-02-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Product will no longer be available upon the depletion of the limited inventory at McKesson. |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-08-07 | French | Compare |
v5 | 2024-08-07 | English | Compare |
v4 | 2024-02-06 | French | Compare |
v3 | 2024-02-06 | English | Compare |
v2 | 2024-01-22 | French | Compare |
v1 | 2024-01-22 | English | Compare |
Showing 1 to 6 of 6